Overview
News
Salaries
Products
People
Growth
Offices
Financials

Overview

Setting a New Standard in Precision Oncology. Next-generation copper-based radiopharmaceuticals enable the highest accuracy and accessibility for targeted cancer treatment.

News

Press release The Manila Times 8 months ago
NUCLIDIUM Announces Issuance of New U.S. Patent Covering its 61Cu-based Radiodiagnostic Program for PSMA-positive Prostate Cancer
Basel, Switzerland / Munich, Germany, January 26, 2026 - NUCLIDIUM AG, a clinical-stage radiopharmaceutical company developing a proprietary copper-based theranostic platform, today announced that U.S. Patent No. 12,527,885 has been granted by the United
Read more
Report
Blog 8 months ago
NUCLIDIUM Announces Issuance of New U.S. Patent Covering its 61Cu-based Radiodiagnostic Program for PSMA-positive Prostate Cancer
NUCLIDIUM Announces Issuance of New U.S. Patent Covering its 61Cu-based Radiodiagnostic Program for PSMA-positive Prostate CancerBasel, Switzerland / Munich, Germany, January 26, 2026 - NUCLIDIUM AG, a clinical-stage radiopharmaceutical company developing
Read more
Report
Blog 11 months ago
NUCLIDIUM Featured in BioCentury Emerging Company Profile
NUCLIDIUM Featured in BioCentury Emerging Company Profile Our CEO Leila Jaafar recently sat down with BioCentury Reporter Tierney Baum to discuss Nuclidium's unique copper-based approach to establish scalable manufacturing of radioligand therapeutics and
Read more
Report
Blog 11 months ago
NUCLIDIUM Presents Positive Phase I/II Results for First Copper-based PET Diagnostic in Neuroendocrine Tumors at EANM Congress 2025
NUCLIDIUM Presents Positive Phase I/II Results for First Copper-based PET Diagnostic in Neuroendocrine Tumors at EANM Congress 202561Cu-TraceNET showed an excellent safety profile and was well tolerated with rapid blood clearance and a favorable half-life
Read more
Report
Pro access
Upgrade to see all 20 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.

People

Anthony Rosenberg
Directors
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1